Viral Kinetics During Acute Chikungunya Virus Infection: Insights Into Potential Role of Monoclonal Antibodies in Viral Clearance and Prophylaxis Using Mathematical Modeling
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Tey Putita Ou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Virology Unit, Pasteur Network, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. Hauptthemen laut MEDLINE: Viral Load, Chikungunya virus, Chikungunya Fever, Antibodies, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: This study was supported with funding from the United States Defense Advanced Projects Agency (DARPA), Grant TIA HR0011-17-3-0002..
Abstract (Originalsprache)
Chikungunya virus (CHIKV), an arthritogenic alphavirus, is a significant public health threat in endemic and newly affected regions. This study investigates viral kinetics, immune responses, and the potential of monoclonal antibody (mAb) therapies to mitigate viraemia and transmission during acute CHIKV infection, providing novel insights into early intervention strategies. Using data from 29 patients in Cambodia, serial sampling and viral load quantification revealed that the population‐average peak viral load occurred ~1.87 days prior to symptom onset. Children demonstrated higher peak viral loads and faster replication rates compared to adults, although symptom severity and burden were similar across age groups. IgM antibodies appeared earlier in adults (median: 4.1 days) than in children (median: 5.1 days; p = 0.036). C‐reactive protein (CRP) levels were transiently elevated in about 50% of patients but showed no correlation with disease severity. Mathematical modeling highlighted that prophylactic mAb therapies, when administered 3 days before symptoms onset, could substantially reduce viral load and potentially prevent detectable viraemia. While these findings underscore the potential of mAbs as an early therapeutic strategy, further studies are necessary to evaluate the robustness of these results and assess their practical implications to curb CHIKV outbreaks by minimizing viraemia and presymptomatic transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virology Unit, Pasteur Network, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
- Epidemiology and Public Health Unit, Pasteur Network, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
- Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, U1332 INSERM, UMR2000 CNRS, Paris, France.
- Epimod, Lent, France.
- Clinical Development and Translational Medicine, Evotec ID, Lyon, France.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Tey Putita Ou, Sowath Ly, Claude Flamand, Nicolas Voirin, Hugh Watson, Veasna Duong
Förderung
- This study was supported with funding from the United States Defense Advanced Projects Agency (DARPA), Grant TIA HR0011-17-3-0002.
Zitieren
APA
Ou, T. P., Sorn, S., Nguon, K., In, S., Ken, S., Ly, S., Flamand, C., Voirin, N., Mandron, M., Watson, H., & Duong, V. (2025). Viral Kinetics During Acute Chikungunya Virus Infection: Insights Into Potential Role of Monoclonal Antibodies in Viral Clearance and Prophylaxis Using Mathematical Modeling. Journal of Medical Virology. https://doi.org/10.1002/jmv.70391
Vancouver
Ou TP, Sorn S, Nguon K, In S, Ken S, Ly S, et al. Viral Kinetics During Acute Chikungunya Virus Infection: Insights Into Potential Role of Monoclonal Antibodies in Viral Clearance and Prophylaxis Using Mathematical Modeling. Journal of Medical Virology. 2025. doi:10.1002/jmv.70391
BibTeX
@article{Ou2025,
author = {Ou, Tey Putita and Sorn, Sopheak and Nguon, Kunthy and In, Saraden and Ken, Sreymom and Ly, Sowath and Flamand, Claude and Voirin, Nicolas and Mandron, Marie and Watson, Hugh and Duong, Veasna},
title = {Viral Kinetics During Acute Chikungunya Virus Infection: Insights Into Potential Role of Monoclonal Antibodies in Viral Clearance and Prophylaxis Using Mathematical Modeling},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70391}
}
EUVIMED